Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Schmitz, Norbert; Nickelsen, Maike; Ziepert, Marita; Haenel, Mathias; Borchmann, Peter; Schmidt, Christian; Viardot, Andreas; Bentz, Martin; Peter, Norma; Ehninger, Gerhard; Doelken, Gottfried; Ruebe, Christian; Truemper, Lorenz; Rosenwald, Andreas; Pfreundschuh, Michael; Loeffler, Markus; Glass, Bertram; German High-Grade Lymphoma Study G

Erstveröffentlichung

2012

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Schmitz, Norbert

Nickelsen, Maike

Ziepert, Marita

Haenel, Mathias

Borchmann, Peter

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

The lancet Oncology ; 13 (2012), 12. - S. 1250-1259. - ISSN 1470-2045. - eISSN 1474-5488

Link to publication

https://dx.doi.org/10.1016/S1470-2045(12)70481-3

Keywords

NON-HODGKINS-LYMPHOMA; BONE-MARROW-TRANSPLANTATION; PLUS ETOPOSIDE MEGACHOEP; CHOP CHEMOTHERAPY; RESPONSE CRITERIA; INITIAL TREATMENT; 3-WEEKLY CHOP; PROGNOSIS; THERAPY; CYCLOPHOSPHAMIDE

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record